| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 130 |
| 1 | PREDNISONE | 119 |
| 2 | ETANERCEPT | 92 |
| 3 | ACETAMINOPHEN | 90 |
| 4 | DUPILUMAB | 82 |
| 5 | ALBUTEROL SULFATE | 81 |
| 6 | METHOTREXATE SODIUM | 80 |
| 7 | METHOTREXATE | 72 |
| 8 | OMALIZUMAB | 70 |
| 9 | SECUKINUMAB | 69 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DEXTROMETHORPHAN HBR, GUAIFENESIN AND PSEUDOEPHEDRINE HCL | 1 | 0.2500 |
| 1 | DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL, PYRILAMINE MALEATE | 1 | 0.1000 |
| 2 | GENTIAN VIOLET | 2 | 0.0385 |
| 3 | NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE | 5 | 0.0189 |
| 4 | FORMALDEHYDE | 1 | 0.0164 |
| 5 | CARBINOXAMINE MALEATE | 3 | 0.0155 |
| 6 | NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE | 3 | 0.0148 |
| 7 | ESTRONE | 1 | 0.0093 |
| 8 | APRACLONIDINE | 1 | 0.0090 |
| 9 | INFLIXIMAB-DYYB | 30 | 0.0087 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 261 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 192 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 169 |
| 3 | Benzodiazepine [EPC] | 118 |
| 4 | Interleukin-4 Receptor alpha Antagonist [EPC] | 82 |
| 5 | Vitamin C [EPC] | 81 |
| 6 | Interleukin-17A Antagonist [EPC] | 80 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 73 |
| 8 | Anti-IgE [EPC] | 70 |
| 9 | Proton Pump Inhibitor [EPC] | 67 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 10 | 0.0145 |
| 1 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 46 | 0.0034 |
| 2 | Interleukin-17A Antagonist [EPC] | 80 | 0.0021 |
| 3 | Provitamin D2 Compound [EPC] | 62 | 0.0021 |
| 4 | Guanylate Cyclase-C Agonist [EPC] | 4 | 0.0019 |
| 5 | CD4-directed Blocking Antibody [EPC] | 1 | 0.0019 |
| 6 | 5-Lipoxygenase Inhibitor [EPC] | 1 | 0.0015 |
| 7 | Cortisol Synthesis Inhibitor [EPC] | 1 | 0.0013 |
| 8 | Quinolone Antimicrobial [EPC] | 12 | 0.0012 |
| 9 | Peroxisome Proliferator-activated Receptor Agonist [EPC] | 1 | 0.0011 |